Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pancreatic carcinoma].

M Böhmig1, S Rosewicz

  • 1Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Berlin.

Zeitschrift Fur Gastroenterologie
|March 17, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective suppression of nuclear retinoic acid receptor beta gene expression in human pancreatic carcinomas.

International journal of oncology·2011
Same author

Phase II pilot trial of preoperative high-dose chemotherapy in patients with malignant tumors of the upper gastrointestinal tract.

International journal of oncology·2011
Same author

Galectin-1 sensitizes carcinoma cells to anoikis via the fibronectin receptor α5β1-integrin.

Cell death and differentiation·2010
Same author

The oral multitarget tumour growth inhibitor, ZK 304709, inhibits growth of pancreatic neuroendocrine tumours in an orthotopic mouse model.

Gut·2008
Same author

Health-related quality of life in patients with pancreatic cancer.

Digestion·2006
Same author

Impact of FDG-PET/MRI image fusion on the detection of pancreatic cancer.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2006
Same journal

[Version 7.0 of the S3 Guideline on Ulcerative Colitis sets out clearly defined treatment goals, an open treatment sequence, and a call for improved cross-sectoral care].

Zeitschrift fur Gastroenterologie·2026
Same journal

Zeitschrift fur Gastroenterologie·2026
Same journal

Zeitschrift fur Gastroenterologie·2026
Same journal

[Updated S3 guideline on ulcerative colitis].

Zeitschrift fur Gastroenterologie·2026
Same journal

Zeitschrift fur Gastroenterologie·2026
Same journal

Zeitschrift fur Gastroenterologie·2026
See all related articles

Pancreatic cancer has a poor prognosis despite advances. Current diagnostic and treatment strategies offer limited success, highlighting the need for novel approaches to improve patient outcomes.

Area of Science:

  • Oncology
  • Gastroenterology

Context:

  • Pancreatic cancer remains a significant health challenge with a dismal prognosis, despite advancements in epidemiology and molecular genetics.
  • Current diagnostic and therapeutic strategies offer limited efficacy, necessitating a re-evaluation of existing algorithms.

Purpose:

  • To critically analyze published data on pancreatic cancer diagnosis and treatment.
  • To provide recommendations for diagnostic and therapeutic algorithms for suspected pancreatic cancer patients.

Summary:

  • Diagnostic work-up involves ultrasound, MRI, and potentially laparotomy. Resective surgery offers cure in a minority of cases, with adjuvant chemotherapy showing some survival benefit.
  • Locally advanced, unresectable disease may benefit from combined radiochemotherapy. Systemic chemotherapy with Gemcitabine provides marginal survival benefits, while best supportive care is crucial for unresectable cases.

Related Experiment Videos

  • There is an urgent need for innovative diagnostic and therapeutic strategies to improve pancreatic cancer outcomes.

    • Impact:

    • This analysis aims to guide clinical decision-making for pancreatic cancer management.
    • The findings underscore the critical need for developing more effective diagnostic tools and treatments for pancreatic cancer.
    • Improved strategies are essential to enhance survival rates and quality of life for patients diagnosed with pancreatic cancer.